Is diabetes mellitus equivalent to atherosclerotic cardiovascular disease from a healthcare cost perspective? Insights from the Medical Expenditure Panel Survey: 2010–2013

Diabetes mellitus (DM) and atherosclerotic cardiovascular disease (ASCVD) both increase the risk for a major adverse cardiac event, and are therefore considered priority conditions clinically. Although guidelines encourage clinicians to treat them similarly, many researchers do not consider DM an AS...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cardiovasc Endocrinol Metab
Main Authors: Feldman, David I., Valero-Elizondo, Javier, Salami, Joseph A., Rana, Jamal S., Ogunmoroti, Oluseye, Okunrintemi, Victor, Osondu, Chukwuemeka U., Spatz, Erica S., Virani, Salim S., Blankstein, Ron, Blaha, Michael J., Veledar, Emir, Nasir, Khurram
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Health 2018
Fag:
Short Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6739895/
https://ncbi.nlm.nih.gov/pubmed/31646284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/XCE.0000000000000151
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker